4.58
Coya Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
7.18
FY23:
41.2
FY24:
44.3
FY25:
49.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
0.21
FY22:
1.21
FY23:
0.07
FY24:
0.04
FY25:
0.01
Total assets
Change from FY21 to FY25
millions USD
FY21:
4.79
FY22:
8.40
FY23:
41.3
FY24:
44.3
FY25:
50.0
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
1.15
FY22:
3.82
FY23:
5.05
FY24:
3.82
FY25:
5.87
(negative)
millions USD
FY21:
0
FY22:
13.0
FY23:
0.57
FY24:
0.95
FY25:
1.05
(positive)
Change from FY21 to FY25
millions USD
FY21:
3.64
FY22:
−8.39
FY23:
35.6
FY24:
39.6
FY25:
43.0
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
4.79
FY22:
8.40
FY23:
41.3
FY24:
44.3
FY25:
50.0
All amounts in millions USD